Charles Schoch

Interim Chief Financial Officer

Candel Therapeutics

Social profiles

Profile privacy

Get Free Access to Charles’s Contact Info

Connect with Charles Schoch, Now

According to Datanyze information, these are Charles Schoch's contact details. Reveal the hidden information below for FREE!

Phone (Mobile)

+1 857 ❅❅❅ ❅❅❅❅

Phone (Mobile)

Phone (HQ)

(617) 916-5445

Phone (HQ)

❅❅❅❅❅@candeltx.com

❅❅❅❅❅@gmail.com

Office Address (HQ)

117 Kendrick St Ste 450, Needham, Massachusetts, 02494, United States

Office Address (HQ)

Reveal for Free

Work Biography for Charles Schoch, Candel Therapeutics

Charles Schoch works as a Interim Chief Financial Officer at Candel Therapeutics, which is a Business Services company with an estimated 42 employees; and founded in 1999. They are part of the Finance Executive team within the C-Suite Department and their management level is VP-Level. Charles graduated from Northeastern University and is currently based in Needham, United States. They used to work at PwC and Harmonix Music Systems and have used the following emails: @candeltx.com, @pwc.com, @constellationpharma.com.

Follow Charles Schoch on LinkedIn to get to know them better.

Remember this info to help warm up your cold call with Charles! ❄️

Previous Work Experience

Charles Schoch's career began less then a year ago. Prior to joining Candel Therapeutics, Charles worked at 6 companies.

Corbus Pharmaceuticals

Corporate Controller

PwC

Manager

Harmonix Music Systems

Consultant - Accounting

Biops LLC

Owner

Codon Devices

Manager, Purchasing Lab & Facility

Constellation Pharmaceuticals

Consultant

Education

Bachelor of Science

Elon University

Master of Business Administration

Northeastern University

Charles's Workplace

Candel Therapeutics

At Candel Therapeutics, we are developing viral immunotherapies that are designed to cause in situ vaccination against the unique antigens and neoantigens presented when tumor cells lyse and stimulate activation of both innate and adaptive immune mechanisms. The patient and tumor-specific memory res...Read More

117 Kendrick St Ste 450, Needham, Massachusetts, 02494, United States

$8.9 M

Business Services, Research & Development

Get Full Profile Access

Ice Breakers

Imagine you could know all about Candel Therapeutics - Charles Schoch’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers

Charles’s company in the news

Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting

October 4, 2024

Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

September 3, 2024

Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

August 13, 2024

Insights to Break the Ice

In your first interaction

Charles’s CEO is Pail Tak

Charles is located in United States

Candel Therapeutics’s Funding

Last funding

$23M

April 3, 2019

Total raised

$65M

Work Colleague

See Charles Schoch's coworkers out of Candel Therapeutics's 42 employees

Name & Title	Contact Info
Pail Tak Chief Executive Officer	❅❅❅❅❅@candeltx.com	Reveal for Free
Dana Shkolny Chief of Staff	❅❅❅❅❅@candeltx.com	Reveal for Free
Ileen Winick Chief People Officer	❅❅❅❅❅@candeltx.com	Reveal for Free
Abigail Bracha Vice President, Corporate Development & Strategy		Reveal for Free
David Maheu Vice President, Viral Vector Process & Analytical Development	❅❅❅❅❅@candeltx.com	Reveal for Free
Theodore Jenkins Business Development Vice President, Investor Relations	❅❅❅❅❅@candeltx.com	Reveal for Free
Luis Aguilar Clinical Operations Vice President, Business	❅❅❅❅❅@candeltx.com	Reveal for Free
Jeremy Cox Senior Vice President, Interim Chief Financial Officer, Corporate Controller & Chief Tax Officer	❅❅❅❅❅@hpe.com	Reveal for Free